Send to:

Choose Destination
See comment in PubMed Commons below
CNS Spectr. 2003 Jan;8(1):59-63.

Neuropsychopharmacologic treatment of depression and other neuropsychiatric disorders in HIV-infected individuals.

Author information

  • 1McKnight Brain Institute, Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL 32610-0256, USA.


How can neuropsychiatric disorders and syndromes be underdiagnosed and inadequately treated in individuals infected with human immunodeficiency virus? Depression in particular is among the most prevalent diagnoses and there is a solid foundation of data from controlled clinical studies that has begun to examine the efficacy of various antidepressants in HIV-infected persons. This article summarizes essential findings pertaining to the use of psychotropic medications to treat depression and other neuropsychiatric disorders in the context of immunodeficiency. This includes discussion of clinically significant treatment considerations (eg, efficacy, side effects, drug-drug interactions) derived from the existing literature. Taken together, there is compelling evidence that psychopharmacologic intervention can improve the quality of life of mentally ill HIV-infected individuals.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk